Document:

Exhibit 10.10

PROMISSORY NOTE

 

	$45,000	As of June 25, 2013   

 

MedWorth Acquisition Corp., a Delaware corporation
(“Maker”), promises to pay to the order of Anthony Minnuto (“Payee”) the principal sum of Forty-five Thousand
and No Cents ($45,000) in lawful money of the United States of America, on the terms and conditions described below.

 

1.          Principal.
The principal balance of this Promissory Note (the “Note”) shall be repayable on the earlier of (i) the date on which
Maker consummates an initial public offering of its securities (“IPO”) or (ii) the date on which Maker determines to
not proceed with such IPO.

 

2.          Interest.
No interest shall accrue on the unpaid principal balance of this Note.

 

3.          Application
of Payments. All payments shall be applied first to payment in full of any costs incurred in the collection of any sum due
under this Note, including (without limitation) reasonable attorneys’ fees, then to the payment in full of any late charges
and finally to the reduction of the unpaid principal balance of this Note.

 

4.          Events
of Default. The following shall constitute Events of Default:

 

(a)          Failure
to Make Required Payments. Failure by Maker to pay the principal of this Note within five (5) business days following the date
when due.

 

(b)          Voluntary
Bankruptcy, Etc. The commencement by Maker of a voluntary case under the U.S. Bankruptcy Code, as now constituted or hereafter
amended, or any other applicable federal or state bankruptcy, insolvency, reorganization, rehabilitation or other similar law,
or the consent by it to the appointment of or taking possession by a receiver, liquidator, assignee, trustee, custodian, sequestrator
(or other similar official) of Maker or for any substantial part of its property, or the making by it of any assignment for the
benefit of creditors, or the failure of Maker generally to pay its debts as such debts become due, or the taking of corporate action
by Maker in furtherance of any of the foregoing.

 

(c)          Involuntary
Bankruptcy, Etc. The entry of a decree or order for relief by a court having jurisdiction in the premises in respect of Maker
in an involuntary case under the U.S. Bankruptcy Code, as now or hereafter constituted, or any other applicable federal or state
bankruptcy, insolvency or other similar law, or appointing a receiver, liquidator, assignee, custodian, trustee, sequestrator (or
similar official) of Maker or for any substantial part of its property, or ordering the winding-up or liquidation of its affairs,
and the continuance of any such decree or order unstayed and in effect for a period of sixty (60) consecutive days.

 

    	 

    	 

    

 

(d)          Cross
Default. Maker shall have defaulted under that certain promissory note dated as of February 22, 2013 with in the principal
amount of $62,500 made in favor of Charles F. Fistel (the "Additional Payee") or that certain promissory note dated as
of February 22, 2013 with the principal amount of $62,500 made in favor of the Payee.

 

5.          Remedies.

 

(a)          Upon
the occurrence of an Event of Default specified in Section 4(a), Payee may, by written notice to Maker, declare this Note to be
due and payable, whereupon the principal amount of this Note, and all other amounts payable thereunder, shall become immediately
due and payable without presentment, demand, protest or other notice of any kind, all of which are hereby expressly waived, anything
contained herein or in the documents evidencing the same to the contrary notwithstanding.

 

(b)          Upon
the occurrence of an Event of Default specified in Sections 4(b), 4(c) or 4(d), the unpaid principal balance of, and all other
sums payable with regard to, this Note shall automatically and immediately become due and payable, in all cases without any action
on the part of Payee.

 

6.          Waivers.
Maker and all endorsers and guarantors of, and sureties for, this Note waive presentment for payment, demand, notice of dishonor,
protest, and notice of protest with regard to the Note, all errors, defects and imperfections in any proceedings instituted by
Payee under the terms of this Note, and all benefits that might accrue to Maker by virtue of any present or future laws exempting
any property, real or personal, or any part of the proceeds arising from any sale of any such property, from attachment, levy or
sale under execution, or providing for any stay of execution, exemption from civil process, or extension of time for payment.

 

7.          Unconditional
Liability. Maker agrees that its liability shall be unconditional, without regard to the liability of any other party, and
shall not be affected in any manner by any indulgence, extension of time, renewal, waiver or modification granted or consented
to by Payee or the Additional Payee, and consents to any and all extensions of time, renewals, waivers, or modifications that may
be granted by Payee with respect to the payment or other provisions of this Note, and agree that additional makers, endorsers,
guarantors, or sureties may become parties hereto without notice to them or affecting their liability hereunder.

 

8.          Notices.
Any notice called for hereunder shall be deemed properly given if (i) sent by certified mail, return receipt requested, (ii) personally
delivered, (iii) dispatched by any form of private or governmental express mail or delivery service providing receipted delivery,
(iv) sent by telefacsimile or (v) sent by e-mail, to the following addresses or to such other address as either party may designate
by notice in accordance with this Section:

 

	If to Maker:	MedWorth Acquisition Corp.  
	 	999 Brickell Avenue
	 	Suite 800
	 	Miami, FL  33131
	 	Fascimile: 305-395-5219
	 	aminnuto@medworthgroup.com

 

    	2

    	 

    

 

	If to Payee:	801 Brickell Avenue
	 	Suite 943
	 	Miami, FL  33131
	 	Fascimile: 305-395-5219
	 	medworth1@gmail.com

 

Notice shall be deemed given on the earlier
of (i) actual receipt by the receiving party, (ii) the date shown on a telefacsimile transmission confirmation, (iii) the date
on which an e-mail transmission was received by the receiving party’s on-line access provider, (iv) the date reflected on
a signed delivery receipt, or (vi) two (2) business days following tender of delivery or dispatch by express mail or delivery service.

 

9.          Governing
Law. This Note shall be construed and enforced in accordance with the domestic, internal law, but not the law of conflict of
laws, of the State of Florida .

 

10.         Severability.
Any provision contained in this Note which is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be
ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any
such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other
jurisdiction.

 

IN WITNESS WHEREOF, Maker, intending to
be legally bound hereby, has caused this Note to be duly executed by its duly authorized officer effective as of the day and year
first above written.

 

	 	MEDWORTH ACQUISITION CORP.
	 	 	 
	 	By:	/s/ Charles F. Fistel
	 	 	Charles F. Fistel, Chief Executive Officer

 

    	3Exhibit 10.14

Subscription Agreement

 

	 	As of June 26, 2013

 

To the Board of Directors of

MedWorth Acquisition Corp.:

 

Gentlemen:

 

In addition to the shares previously subscribed
for pursuant to the undersigned’s Subscription Agreement dated March 26, 2013, the undersigned hereby subscribes for and
agrees to purchase 29,250 shares of common stock (“Sponsors’ Shares”) of MedWorth Acquisition Corp. (the “Corporation”),
at $8.00 per Sponsor Share (the “Purchase Price”). EarlyBirdCapital, Inc. is acting as representative of the underwriters
in the Corporation’s initial public offering (the “IPO”). In addition, if the underwriters in the IPO exercise
the over-allotment option, in part or in full, the undersigned agrees to purchase up to an additional 7,200 Sponsors’ Shares,
pro rata based on the percentage of the overallotment option that is exercised (the “Over-allotment Sponsors’ Shares”),
at $8.00 per Sponsor Share (the “Over-allotment Purchase Price”). The Sponsors’ Shares and Over-allotment Sponsors’
Shares will be sold to the undersigned on a private placement basis and not as part of the IPO.

 

Not later than June 27, 2013, or one business
day prior to the closing of the over-allotment option, as the case may be, the undersigned shall wire the Purchase Price, or the
Over-Allotment Purchase Price, as the case may be, to Broad and Cassel, as escrow agent (“Escrow Agent”), to hold in
a non-interest bearing account until the Corporation consummates the IPO, or the over-allotment option exercise, as the case may
be. The closing of the sale of the Sponsor Shares or the Over-allotment Sponsors’ Shares will take place simultaneously with
the consummation of the IPO or the over-allotment option exercise, as the case may be. Immediately prior to the consummation of
the IPO or the over-allotment option exercise, as the case may be, the Escrow Agent shall deposit the Purchase Price or the Over-allotment
Purchase Price, as the case may be, without interest or deduction, into the trust account established by the Corporation for the
benefit of the Corporation’s public shareholders as described in the Registration Statement, pursuant to the terms of an
Investment Management Trust Agreement to be entered into between the Corporation and Continental Stock Transfer & Trust Company.
In the event that the IPO is not consummated within 14 days of the date the Purchase Price is delivered to the Escrow Agent, the
Escrow Agent shall return the Purchase Price to the undersigned, without interest or deduction.

 

    	1

    	 

    

 

The undersigned represents and warrants
that he/she/it has been advised that the Sponsors’ Shares and Over-allotment Sponsors’ Shares have not been registered
under the Securities Act of 1933, as amended (the “Securities Act”); that he/she/it is acquiring the Sponsors’
Shares and Over-allotment Sponsors’ Shares for his/her/its account for investment purposes only; that he/she/it has no present
intention of selling or otherwise disposing of the Sponsors’ Shares or Over-allotment Sponsors Shares in violation of the
securities laws of the United States; that he/she/it is an “accredited investor” as defined by Rule 501 of Regulation
D promulgated under the Securities Act; and that he/she/it is familiar with the proposed business, management, financial condition
and affairs of the Corporation. The undersigned hereby waives any and all right, title, interest or claim of any kind in or to
any liquidating distribution by the Corporation with respect to the Sponsors’ Shares or Over-allotment Sponsors’ Shares
if the Corporation does not complete a Business Combination (defined below).

 

The undersigned agrees that he/she/it shall
not sell or transfer the Sponsors’ Shares or Over-allotment Sponsors’ Shares until the Corporation consummates a merger,
share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination (“Business
Combination”) with one or more businesses or entities as more fully described in the Registration Statement (except for transfers
(i) to officers, directors and employees of the Corporation and, if the undersigned is an entity, as a distribution to partners,
members or stockholders of the undersigned upon the liquidation and dissolution of the undersigned, (ii) by bona fide gift to a
member of the undersigned’s immediate family or to a trust, the beneficiary of which is the undersigned or a member of the
undersigned’s immediate family for estate planning purposes, (iii) by virtue of the laws of descent and distribution upon
death of the undersigned, (iv) pursuant to a qualified domestic relations order, (v) with the Company’s prior written consent,
by certain pledges to secure obligations incurred in connection with purchases of the Company’s securities; (vi) by private
sales at prices no greater than the price at which the Sponsors’ Shares or Over-allotment Sponsors’ Shares were originally
purchased or (vii) to the Corporation for cancellation in connection with the consummation of a Business Combination, in each case,
except for clause (vii), on the condition that such transfers comply with applicable securities laws, in the opinion of counsel
to the Corporation, and that such transfers may be implemented only upon the respective transferee’s written agreement to
be bound by the transfer restrictions of this Subscription Agreement). The undersigned acknowledges that the certificates for such
Sponsors’ Shares and Over-allotment Sponsors Shares shall contain a legend indicating such restriction on transferability.

 

Each party hereto hereby acknowledges that
the underwriters of the IPO are third party beneficiaries of this Subscription Agreement, and this Subscription Agreement may not
be modified or changed without the prior written consent of EarlyBirdCapital, Inc.

 

	 	Very truly yours,
	 	 
	 	/s/ Anthony Minnuto
	 	Anthony Minnuto

 

    	2

    	 

    

 

Agreed to:

MedWorth Acquisition Corp.

 

	By:	/s/ Charles F. Fistel	 
	 	Name:   Charles F. Fistel	 
	 	Title:     Chief Executive Officer	 
	 	 	 
	Broad and Cassel, solely as Escrow Agent	 
	 	 	 
	By:	/s/ Nina S. Gordon	 
	 	Name:  Nina S. Gordon	 
	 	Title:    President, Nina S. Gordon, P.A., Partner	 

 

    	3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00218-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00218-of-00352.parquet"}]]